| 1 |
32472569 | Tablets or oral suspension for posaconazole in lung transplant recipients? Consequences for trough concentrations of tacrolimus and everolimus. | 2021 Feb |
1 |
| 2 |
30259783 | Posaconazole-digoxin drug-drug interaction mediated by inhibition of P-glycoprotein. | 2019 Oct |
3 |
| 3 |
31741622 | Factors Influencing the Safety and Efficiency of Antifungal Prophylaxis with Posaconazole in Children with Hematological Diseases: From Genetics to Polypharmacotherapy. | 2019 Oct |
2 |
| 4 |
29578577 | Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects. | 2018 Jul |
2 |
| 5 |
27530244 | Severe palmar-plantar erythrodysesthesia and aplasia in an adult undergoing re-induction treatment with high-dose cytarabine for acute myelogenous leukemia: a possible drug interaction between posaconazole and cytarabine. | 2017 Sep |
1 |
| 6 |
27001813 | Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP. | 2016 Jun |
1 |
| 7 |
27510521 | Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction. | 2016 Nov |
1 |
| 8 |
21420575 | [Drug interactions in critically-ill patients. An important factor in the use of micafungin?]. | 2011 Mar |
1 |